Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL + B-Lineage Acute Lymphoblastic Leukemia.
Autor: | Budhraja A; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Turnis ME; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Churchman ML; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Kothari A; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Yang X; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Xu H; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Kaminska E; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Panetta JC; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Finkelstein D; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Opferman JT; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee. Joseph.Opferman@stjude.org. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Dec 15; Vol. 23 (24), pp. 7558-7568. Date of Electronic Publication: 2017 Oct 03. |
DOI: | 10.1158/1078-0432.CCR-17-1231 |
Abstrakt: | Purpose: BCR-ABL + B-ALL leukemic cells are highly dependent on the expression of endogenous antiapoptotic MCL-1 to promote viability and are resistant to BH3-mimetic agents such as navitoclax (ABT-263) that target BCL-2, BCL-X (©2017 American Association for Cancer Research.) |
Databáze: | MEDLINE |
Externí odkaz: |